Sei sulla pagina 1di 2

MORTALITIES SEPTEMBER 2017

2514 LTAN CENTENO FRANCISCO ARF 2 TO CAPHR ADHF ABG 7.4 PCO2 30.9 PO2 63.2 HCO3 18.9 COM RESPI ALK W/ HYPOXEMIA ASA CLOPI ENOXAPRARINE
616436 70/ M CVA INFARCT L MCA HCVD NSTEMI PROB ISCHEMIC TROPT 0.13 CKMB 22.3 LOSARTAN AMLO
T2DM DCMP FC III ST C CXR: CM, PNM R ATORVASTATIN DIGOXIN
ECG SINUS TACHYARRHYTHMIA, LBBB SILTAGLIPTIN
HGB 132 WBC6.3 B1 S68 PC 196 DOBU 500MG AT 20CC/HR
NA 138 K3.3 CREA 141
PROV ECHO EF 22% SEVERE GLOBAL HK WITH THINNED OUT AKINETIC SEPTUM

GCS 3
DNR CONTYINUE ALL MEDS NO LABS
TPIECE AT 10LPM
CARDIOGENIC SHOCK ACS 8/31 HGB 104 WBC 13 PLT 207 NA 141 K 4 CREA 82 PLAN OF RELATIVES TO BRING
CAP-MR NSTEMI 8/30 CXR: REGR OF BPC PATIENT HOME
1405 MILAGROS VIOLETA
ADC T2DM HCVD 3V CAD CREA 99 NA 133 K 3.9 WBC 16.7 HGB 116 APC 243 AC MODE 30%
615936 64/F ECG: CLBBB POSSIBLE TPIECE TOM
SEIZURE EPISODE SEC TO HIE HFPEF NYHA IIIC
CXR: BILAT PULMO CONGESTION PNA ENALAPRIL IVABRADINE
S/P ARREST (2 EPIS) 8/27 AMLO
CLOP ATOR ENOX
8/27 TAZO KEPPRA DIAZEPAM CITI
CCU9 MOG BENJAMIN ARF 2 TO CAP-HR, AKI ON PROB CAD, ST>AF RVR> VT> 12L ECG 9/8: SINUS TACHYCARDIA, CRBBB NPO
MANLAPIG 88/M TOP OF CKD 2 TO MVR CXR: INF RIGHT TO MID LOWER LOBE NGT BSB
DEHYDRATION VS INFECTION S/P ARREST 3X 9/8: TROP 0.71 CKMM 126.8 SGPT 35 SGOT 113, ALB 25, WBC 15 HGB 122 PLT
101 BANDS 11 SEG 78 AC 100%
S/P CARDIOVERT 1X
PROVISIONAL ECHO EF 40% HYPOKINESIA OF ENTIRE IVS, DISTAL HALF OF
S/P FEMCATH,RIGHT INSERTION LVFW, ,MILD MR, MILD TR, AI +1 R NE 8MG 10CC (0.08 UKM)
DOBUTAMINE 250MG 10CC
(2.22UKM)
L PNSS + 1 VIAL ALB 120CC
INSULIN DRIP 1UNIT/HR
PANTOPRAZOLE 25CC
COENZYME Q, TRIMETZIDINE,
CITICOLINE
ICU 6 LTAN VITUG, ROMARICO HAP HCVD, VHD, MOD AS WBC 36.7 HGB 130 PC 243 BANDS 1 NA 141 K 4.2 CKMB 61 TROP T 0.01 FOR UTZ OF CHEST & CXR
100 YO/ M LEFT HIP FRACTURE 2 TO PAROXYSMAL AF, NYHA FCII POST SLED 9/9
EF 64% MOD CALCIFIC AS W/ AVA 1.36CM BY CE PG 0F 43, THOICKENED AND CALCIFIIED
FALL AORTIC CUSPS W/ ROM, CONC LV REMODELLING AWMC, DIL RVC, BIATRIAL DIL, MOD
OF 100 Q6
CKD 2 TO DM NEPHROPATH PULMO HTN
1LPM NC
ON MAINTAINANCE HD MWF
9/7: MEROPENEM 9/7 D2
NOREPI 4MG 8CC

ROSUVASTATIN, NAC,
AMIODARONE
ANTIEMBOLIC STOCKINGS
BONE TRACTION
HYPOVOLEMIC SHOCK 2 TO
CCU4 ADC IVY SIA 37/F RUPTURED UTERUS S/P E
EXLAP
01 LTAN GLORIA CORTEZ 54F CVA BLEED R 9/11 HGB 115 WBC12.9 S87 PC 159 AC FIO2 30%
616914 PARIETOTEMPORAL (43CC) NA 165 K3.6 CREA 192 MG 0.94 CLONIGEN
W/ IVE 9/7 WBC 22.3 HGB 132 PLT 252 NA 139 K 1.6 CREA 100 ICA 1.13 MG 0.68 MANNITOL 150CC Q4
ECG FRQ PVC AMLO
DEXA KEPPRA METOPROLOL
9/11 LEVOFLOXACIN
9/10 PT 18.6/1.44/54% DNR
HAP CHEST UTZ W/ POSSIBLE
CXR: INT REGRESSION OF BPC, NO CHANGE IN PLEURAL FLUID
PLEURAL EFFUSION B THORA TODAY
9/9 WBC 14.2 HGB 112 PLT 62 SEG 84
AKI PROB SEC TO INFECTION SECURE 2 U FFP
K 3.7 CREA 127
S/P TRACHEOSTOMY HCVD LONG STANDING AF
1510 9/7 CHESRT UTZ: L 280 R 600CC W/ ATELEC
ASY SOLITA ANGELS 87/F (4/2017) CHADSVASC 4 HASBLED 2
616799 9/6 WBC 7.6 HGB 111 PLT 85 ISDN BENEPROTEIN
S/P BRONCHOSCOPY AND NYHA FC II
PT 17.4 INR 1.34 ACT 61% PANTOPRAZOLE
CHANGE OF TRACHE 7/10
SUPRASTERNAL NA 152 K 3.6 NEBIVOLOL ALBUMIN +FURO
GRANULOMA TP 68 ALB 28 GLOB 40 A/G 0.70 CREA 129 20 Q12
7/2017 EF 53% ECCENTRIC LVH HYPOKINESIA INF IVS, INF LVFW B-A
ICU4 ADC ROBERTA SEPSIS 2 TO HAP VS BLOOD ADHF HCVD PROB CAD 9/11: WBC 0.8 HGB 96 PLT 16 NA 139 SEG 78 NA 139 K 3.9 SGPT 80 CBC NA K SGPT 9/12
616538 DOMANTAY 77F DYSCRASIA NYHA FC IIIC 9/10: MG 0.74 SLED 9/21
CKD SEC TO HPN S/P PPI DDD JAN 2017 9/9 ICA 1.13 MG 0.65 K 3 LDH 1913 FOR TRANFUSION 1 U PLT
(TRESHOLD A 0.5 V 0.75) 9/8: CBC WBC 1.4 HGB 84 DEG 75 PLT 6 K 4.1 SGPT 59 CREA 333 ALB 16 PHERESIS DURING SLED
9/6 CREA 646 K 2.9 BUN 56.3 WBC 7 HGB 89 PLT 8 BANDS 5 SEG 20 CXR BPC ALTRAQ 150 Q6
9/5 NA 134 K3.3 CREA 607
9/3 HGB 89 WBC 10.9 PLT 94 NA 132 K 4.9 CREA 629 D5LR 80CC/HR
ECG VPACED NE 8MG 14CC TO TITRATE BY
1CC/HR TO MAINTAIN SBP
>=120 (0.08UKM)
PITRE 10CC
DOPAMINE 400MG 5CC (2.9
UKM)

AC 40% PEEP 3

MEROP 9/5 D7
CIPRO 9/10 D3
METRO 9/10 D2
NOREPI 8MG X 15CC/HR
TAPERING

SIMVAS ISMN TMZ ALB OD


1523A BORBE AMALIA ALICANDO HAP VS PULMO METS 9/12: REG OF PNM INFILTRATES L9/9 CXR: INC INFILTRATES L LUNG DNR DNI
616572 53F T/C BRAIN METS NA K CBC NBE
9/7 BLD CS NEG NA 121 K3.8 CREA 33 HGB 117 WBC9.4 PC 140
BREAST CA R 9/9 MEROPENEM/LEVOFLOX/
9/6 2DE: EF 66% N LVD w/ adeq wall motion and contractility W/ gr II 9/9 FLUCO
S/P MRM
LV diastolic dysfunction N RVD w/ N contractility N LA Aortic and mitral NAC SALB NEB UDCA AMLO
S/P 6TH CYCLE CHEMO NYSTATIN
ORAL CANDIDIASIS sclerosis Mild TR N thrombus and PE N PAP
MANNITOL 100CC Q8
NA 134 K3.4 CREA 188 MG0.98 HGB 98 WBC10.2 S75 PC 328
CXR: MULTIPLE CIRCULAR HOMOGENOUS DENSITY PROB METS, INFIL
RLL
WBC 10 HGB 133 PLT 120 NA 128 K 3.4 CREA 55 MG 0.79
3508 TDY ROSA KAU LIM 88F HIE SEC TO CP ARREST HASCVD, 3VCAD, S/P CABG 2012 9/13 WBC 12.2 NA 132 K 3.4 CREA 131 ICA 1.09 MG 0.76 DNR/DNI/NO DEIB/D/C ALL
ARF SEC TO ASPIRATION AND PPI DDD 2012 PROB SSSS 9/13 CREA 95 K 3.7 MEDS
PNEUMONIA (SLMC( 5/2017 VENOUS: NO EVIDENCE OF DVT IN BILATERAL LOWER EXT, DEEP VEIN NO INOTROPES
T2DM SEVERE PAOD LEFT >RIGHT VALVE INCOMPETENCE UN THE RIGHT FEM, TIBIOPERONEAL TRUNK AND ANT PIPTAZO
CKD SEC TO DMN VS HPN FONTAINE III-IV, RUTHERFORD 6 TIBIAL VEINS,VENOUS HPN, TISSUE EDNEA IB BILAT LEGS AC MODE 40%> TPC 40% FI02
S/P CA-FA 9/13 WBC 7.8 HGB 134 PC166 S64
CREA101 K4 PT11.6 INR1/.02 ACT 95.8%
S/P CP ARREST (3EPI) APTT32 NC 29.1S
CARDIAC DYSRRHYTMIA CXR PNEUMONIA VS CILC
(VFIBTORSADES) S/P DEFIB 200J 5/2017 ARTERIAL: RIGHT: >50% STENOSIS SFA PROX, TO SFA DISTAL, PTA PROX
MID DISTAL, NTO ATA MID ; LEFT: >50% STENOSIS SFA, TO PTA PROX MID
DISTAL ATA MID DISTAL
7/2017 ECHO: N LVD W/ SEGMENTAL WALL MOTION ABN CONSISTENT W/
CAD; SEVERE HK IVS AND ANT WALL FR B-A. THE INF, INFEROLAT, AND
ANTEROLAT LVFW CONTRACTS ADEQ AT BASE TO MID SEGMENT W. SVERE HK
AT THE APEX. DILATED RA, LA, SLIGHTLY DIL RV W/ NWT, MILD PULMO HTN
W/ ESPAP 49MMHG
ICU6 ADC MARCELINO MERCED CKD 2 BPH ACS, NSTE ANTEROLATERAL 9/18: CREA 237 MG 1.04 K 4.6 wbc 91.5 hgb 150 apc 199 seg 97 UTZ WA TODAY CREA 9/19
617670 75/M CAP MR WALL SR FC II 2ded EF 54% DILATED LV HK ANT IVS & ANT LVFW B-A, N RV NC, MILD MR AR Dat with sap
TR, N PAP CPAP 50%
9/17: HGB 130 WBC 11.0 SEG 80 PC 166 K 2.9 CREA 170 MG 0.79 SGPT 34 NA
139 LEVOPHED 8MG 10CC 0.08UKM
ECG: ST DEP V3-V6 DOBUTAMINE 250MG 10CC 2.56
UKM

TAZO 9/18 D3
AZITH 9/17 D3
ASA/CLOPID, ISMN, NAC,
CORALAN, KETOBEST,
ATORVASTATIN, PANOTLOC,
HYDROCORT, CLEXANE
2DED
HIE TTM
GCS3
12L ECG: AF IN MVR>SR NPO
HERPES ZOSTER WBC 6 HGB 97 PLT 166 SEG 68 N 143 K 6.4 CREA 373 ICA1.22, MG 1.18 TROP 0.22 AC 30%
HCVD 2V CAD VTACH>AF>SR S/P
ERNESTO PINERA CKD, T2DM, PTB CLASS 5 DDIMER 2
CCU2 WTDG ARREST 9/25 NOREPI 8MG 5CC
65/M S/P CVD INFARCT RIGHT
SIDED RESIDUAL 2008
LEVITERACETAM, PHENYTOIN, NAC,
S/P TRACHE 1/23 DOXOFYLLINE, ATORVASTATIN

Potrebbero piacerti anche